Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pasireotide proof-of-concept study in prolactinoma
2006-007036-95Phase 2Terminated
- Sponsor
- Universitätsmedizin Essen
- Start
- Jan 2009
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of pasireotide LAR in prolactinoma (2 arms), sponsored by Universitätsmedizin Essen. Started Jan 2009; status: terminated.
02
Drugs
pasireotide LAR
03
Conditions
prolactinoma
Beyond the preview
Go deeper on 2006-007036-95.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-007036-95.